Literature DB >> 6333684

Amino acid sequence and post-translational modification of human interleukin 2.

R J Robb, R M Kutny, M Panico, H R Morris, V Chowdhry.   

Abstract

Human interleukin 2 was separated into multiple molecular forms by selective immunoaffinity chromatography and chromatofocusing. For the most part, this heterogeneity was attributed to variations in glycosylation of the threonine residue in position 3 of the polypeptide chain. The various molecular forms of interleukin 2 had nearly identical specific activities in the in vitro proliferation assay, indicating that the glycosylation had no significant effect on this response. The entire primary sequence of interleukin 2, including the location of the intramolecular disulfide bridge, was determined by a combination of peptide mapping and protein sequencing. This information should aid in the determination of the active site(s) of the molecule.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6333684      PMCID: PMC391949          DOI: 10.1073/pnas.81.20.6486

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  9 in total

Review 1.  Comparative aspects of glycoprotein structure.

Authors:  R Kornfeld; S Kornfeld
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

2.  Posttranslational modification of human T-cell growth factor.

Authors:  R J Robb; R M Kutny; M Panico; H Morris; W F DeGrado; V Chowdhry
Journal:  Biochem Biophys Res Commun       Date:  1983-11-15       Impact factor: 3.575

3.  Heterogeneity of human T-cell growth factor(s) due to variable glycosylation.

Authors:  R J Robb; K A Smith
Journal:  Mol Immunol       Date:  1981-12       Impact factor: 4.407

Review 4.  T-cell growth factor.

Authors:  K A Smith
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

5.  A rapid, large scale purification procedure for gibbon interleukin 2.

Authors:  L E Henderson; J F Hewetson; R F Hopkins; R C Sowder; R H Neubauer; H Rabin
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

6.  Purification and partial sequence analysis of human T-cell growth factor.

Authors:  R J Robb; R M Kutny; V Chowdhry
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

7.  Structure and expression of a cloned cDNA for human interleukin-2.

Authors:  T Taniguchi; H Matsui; T Fujita; C Takaoka; N Kashima; R Yoshimoto; J Hamuro
Journal:  Nature       Date:  1983 Mar 24-30       Impact factor: 49.962

8.  Molecular cloning of human interleukin 2 cDNA and its expression in E. coli.

Authors:  R Devos; G Plaetinck; H Cheroutre; G Simons; W Degrave; J Tavernier; E Remaut; W Fiers
Journal:  Nucleic Acids Res       Date:  1983-07-11       Impact factor: 16.971

9.  Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2.

Authors:  A Altman; A N Theofilopoulos; R Weiner; D H Katz; F J Dixon
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

  9 in total
  18 in total

1.  Prediction of mucin-type O-glycosylation sites by a two-staged strategy.

Authors:  YuDong Cai; JianFeng He; Lin Lu
Journal:  Mol Divers       Date:  2010-07-22       Impact factor: 2.943

2.  Amino acid distributions around O-linked glycosylation sites.

Authors:  I B Wilson; Y Gavel; G von Heijne
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

3.  Size polymorphisms due to changes in the number of O-glycosylated tandem repeats in the Dictyostelium discoideum glycoprotein PsA.

Authors:  A A Gooley; R Marshchalek; K L Williams
Journal:  Genetics       Date:  1992-04       Impact factor: 4.562

4.  NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility.

Authors:  J E Hansen; O Lund; N Tolstrup; A A Gooley; K L Williams; S Brunak
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

Review 5.  Fast atom bombardment mass spectrometry and its application to the analysis of some peptides and proteins.

Authors:  M E Hemling
Journal:  Pharm Res       Date:  1987-02       Impact factor: 4.200

6.  Insufficient (sub-native) helix content in soluble/solid aggregates of recombinant and engineered forms of IL-2 throws light on how aggregated IL-2 is biologically active.

Authors:  Uzma Fatima; Balvinder Singh; Karthikeyan Subramanian; Purnananda Guptasarma
Journal:  Protein J       Date:  2012-10       Impact factor: 2.371

7.  Identification of a human non-interferon lymphokine activating monocyte complement biosynthesis.

Authors:  C Drouet; A Reboul; M Colomb
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

8.  Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin supergene family.

Authors:  R J Paxton; G Mooser; H Pande; T D Lee; J E Shively
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

9.  Design, synthesis and expression of a human interleukin-2 gene incorporating the codon usage bias found in highly expressed Escherichia coli genes.

Authors:  D P Williams; D Regier; D Akiyoshi; F Genbauffe; J R Murphy
Journal:  Nucleic Acids Res       Date:  1988-11-25       Impact factor: 16.971

10.  Cloning, sequence, and expression of bovine interleukin 2.

Authors:  D P Cerretti; K McKereghan; A Larsen; M A Cantrell; D Anderson; S Gillis; D Cosman; P E Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.